Lin Yang Biotech Pharmaceutical Co., Ltd.

Lin Yang Biotechnology (Genovior, founded in Taiwan in 2015 and acquired in 2025) is a professional sterile injection drug CDMO, which provides process development, amplification and formulation development for global pharmaceutical companies under the international PIC/S GMP (cGMP, EU GMP) specifications. The 'Small-Scale Injection Manufacturing' service page of the official website clearly provides' high quality filling services for glass bottle liquid/lyophilized dosage forms, syringe injections, cassettes, and dual-chamber prefilled syringes and cassettes', and is manufactured in accordance with PIC/S GMP, EU and US FDA specifications; in addition, it provides drug lyophilization technology development, packaging material design, clinical random code labeling and packaging. It has the preclinical-clinical-commercial mass production capacity of biological APIs such as polypeptides/proteins and monoclonal antibodies and sterile biological injections. It has advanced factories and R&D bases in Hsinchu and Tainan, Taiwan. It is one of the few CDMOs in Asia that can actually carry out mass production of APIs and injections.